Atazanavir + Ritonavir Tablets

Atazanavir + Ritonavir Tablets are a fixed-dose antiretroviral combination used in the treatment of human immunodeficiency virus (HIV-1) infections. Atazanavir is a protease inhibitor, while ritonavir acts as a pharmacokinetic booster that enhances the effectiveness of atazanavir by increasing its concentration in the bloodstream. Together, they help control HIV replication as part of combination antiretroviral therapy (ART).

This combination is commonly prescribed for both treatment-naïve and treatment-experienced HIV patients. Atazanavir + Ritonavir tablets help reduce viral load and support immune system recovery by improving CD4 cell counts when taken regularly under medical supervision. Consistent adherence to the prescribed regimen is essential for optimal therapeutic outcomes.

Atazanavir + Ritonavir tablets follow strict pharmaceutical quality standards to ensure safety, consistency, and effectiveness. This pharmaceutical product is widely used in hospitals, clinics, and healthcare institutions and plays an important role in long-term HIV treatment and management programs.

Product Features

• Combination of Atazanavir and Ritonavir
• Protease inhibitor with pharmacokinetic booster
• Used in combination with antiretroviral therapy (ART)
• Helps maintain effective plasma drug levels
• Meets established pharmaceutical quality standards

How It Helps

• Inhibits HIV protease enzyme to block viral replication
• Ritonavir boosts Atazanavir activity and exposure
• Helps reduce the HIV viral load in the blood
• Supports immune system improvement
• Helps slow the progression of HIV infection